Obesity and metabolic disorders may be risk factors for AAA, with MRAP2 regulating appetite and energy balance, potentially indirectly affecting AAA-related risk factors such as hypertension and atherosclerosis (40, 41). Here, MRAP2 is linked to metabolic disease.